Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans
- PMID: 17264719
- DOI: 10.1097/00000542-200702000-00013
Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans
Abstract
Background: Endothelial cells can be protected against cytokine-induced toxicity by volatile anesthetics. The authors tested whether inhalation of sevoflurane at subanesthetic concentrations provides protection against postocclusive endothelial dysfunction induced by ischemia-reperfusion injury of the forearm in humans.
Methods: Five healthy male volunteers were enrolled in this study with crossover design. Each subject was randomly exposed to 15 min of forearm ischemia in the presence or absence of sevoflurane. Sevoflurane was inhaled at 0.5-1 vol% end-tidal concentrations from 15 min before ischemia until 5 min after the onset of reperfusion. Hyperemic reaction, an indicator of ischemic injury and endothelial function, was determined at 15 and 30 min of reperfusion using venous occlusion plethysmography. Also, markers of leukocyte activation (CD11b, CD42b) were measured by flow cytometry during reperfusion.
Results: Fifteen minutes of forearm ischemia followed by reperfusion diminished postocclusive endothelium-dependent hyperemic reaction at 15 and 30 min of reperfusion. Peri-ischemic inhalation of sevoflurane, targeted at 0.5-1 vol% end-tidal concentrations, markedly improved postocclusive hyperemic reaction. In addition, inhalation of sevoflurane attenuated activation of leukocytes, as measured by CD11b expression, after ischemia-reperfusion injury. No changes in CD42b expression were observed after ischemia-reperfusion of the forearm.
Conclusions: These data suggest that human endothelium, a key component of all vital organs, is receptive to protection by sevoflurane in vivo. Peri-ischemic administration of sevoflurane mimics a combination of pharmacologic preconditioning and postconditioning and protects at even low sedative concentrations (< 1 vol%). Inhibition of leukocyte adhesion is likely to be involved in the protection.
Similar articles
-
Helium breathing provides modest antiinflammatory, but no endothelial protection against ischemia-reperfusion injury in humans in vivo.Anesth Analg. 2009 Jul;109(1):101-8. doi: 10.1213/ane.0b013e3181a27e4b. Anesth Analg. 2009. PMID: 19535699 Clinical Trial.
-
Sevoflurane reduces leukocyte and platelet adhesion after ischemia-reperfusion by protecting the endothelial glycocalyx.Anesthesiology. 2011 Sep;115(3):483-91. doi: 10.1097/ALN.0b013e3182289988. Anesthesiology. 2011. PMID: 21785339
-
Stem cell-like human endothelial progenitors show enhanced colony-forming capacity after brief sevoflurane exposure: preconditioning of angiogenic cells by volatile anesthetics.Anesth Analg. 2009 Oct;109(4):1117-26. doi: 10.1213/ANE.0b013e3181b5a277. Anesth Analg. 2009. PMID: 19762739 Clinical Trial.
-
Molecular Aspects of Volatile Anesthetic-Induced Organ Protection and Its Potential in Kidney Transplantation.Int J Mol Sci. 2021 Mar 8;22(5):2727. doi: 10.3390/ijms22052727. Int J Mol Sci. 2021. PMID: 33800423 Free PMC article. Review.
-
Experimental and Clinical Aspects of Sevoflurane Preconditioning and Postconditioning to Alleviate Hepatic Ischemia-Reperfusion Injury: A Scoping Review.Int J Mol Sci. 2023 Jan 25;24(3):2340. doi: 10.3390/ijms24032340. Int J Mol Sci. 2023. PMID: 36768670 Free PMC article.
Cited by
-
Analysis of Volatile Anesthetic-Induced Organ Protection in Simultaneous Pancreas-Kidney Transplantation.J Clin Med. 2022 Jun 13;11(12):3385. doi: 10.3390/jcm11123385. J Clin Med. 2022. PMID: 35743457 Free PMC article.
-
Mechanisms and prospects of ischemic tolerance induced by cerebral preconditioning.Int Neurourol J. 2010 Dec;14(4):203-12. doi: 10.5213/inj.2010.14.4.203. Epub 2010 Dec 31. Int Neurourol J. 2010. PMID: 21253330 Free PMC article.
-
Clinical Applicability of Conditioning Techniques in Ischemia-Reperfusion Injury: A Review of the Literature.Curr Cardiol Rev. 2021;17(3):306-318. doi: 10.2174/1573403X16999200817170619. Curr Cardiol Rev. 2021. PMID: 33109063 Free PMC article. Review.
-
Sevoflurane Dampens Acute Pulmonary Inflammation via the Adenosine Receptor A2B and Heme Oxygenase-1.Cells. 2022 Mar 24;11(7):1094. doi: 10.3390/cells11071094. Cells. 2022. PMID: 35406657 Free PMC article.
-
A comparison of sevoflurane versus sevoflurane-propofol combination on renal function in patients undergoing valvular heart surgery-A prospective randomized controlled pilot study.Ann Card Anaesth. 2021 Apr-Jun;24(2):172-177. doi: 10.4103/aca.ACA_171_19. Ann Card Anaesth. 2021. PMID: 33884972 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials